SEC 13F Intelligence

Nexus Investment Management Ulc / PFE

Nexus Investment Management Ulc’s Pfizer Inc Position

Does Nexus Investment Management Ulc own Pfizer Inc (PFE)? Yes — 1.03M shares worth $29M (+4.05% of its 13F portfolio) as of Q1 2026, up from 991.2K shares the prior filed quarter.

Position Value
$29M
Q1 2026
Shares
1.03M
% of Portfolio
+4.05%
Quarters Held
30
currently held

Position History PFE

Reported value by quarter
Q4 ’18: $30MQ4 ’18Q1 ’19: $28MQ2 ’19: $30MQ3 ’19: $25MQ4 ’19: $27MQ4 ’19Q1 ’20: $23MQ2 ’20: $24MQ3 ’20: $27MQ4 ’20: $28MQ4 ’20Q1 ’21: $28MQ2 ’21: $30MQ3 ’21: $33MQ4 ’21: $46MQ4 ’21Q1 ’22: $40MQ2 ’22: $37MQ3 ’22: $31MQ4 ’22: $36MQ4 ’22Q1 ’23: $30MQ2 ’23: $27MQ3 ’23: $25MQ4 ’23: $21MQ4 ’23Q1 ’24: $23MQ2 ’24: $22MQ3 ’24: $23MQ4 ’24: $22MQ4 ’24Q1 ’25: $32MQ2 ’25: $21MQ3 ’25: $25MQ4 ’25: $25MQ4 ’25Q1 ’26: $29Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.03M$29M+4.05%
Q4 2025991.2K$25M+3.36%
Q3 2025971.5K$25M+3.51%
Q2 2025875.0K$21M+3.17%
Q1 2025866.8K$32M+3.58%
Q4 2024818.3K$22M+2.17%
Q3 2024804.8K$23M+2.28%
Q2 2024800.3K$22M+2.35%
Q1 2024833.8K$23M+2.23%
Q4 2023743.4K$21M+2.23%
Q3 2023741.6K$25M+2.78%
Q2 2023735.7K$27M+2.94%
Q1 2023730.0K$30M+3.29%
Q4 2022711.7K$36M+4.12%
Q3 2022708.0K$31M+3.86%
Q2 2022702.1K$37M+4.23%
Q1 2022763.2K$40M+4.15%
Q4 2021773.6K$46M+4.65%
Q3 2021772.1K$33M+3.59%
Q2 2021778.8K$30M+3.15%
Q1 2021778.1K$28M+3.21%
Q4 2020741.8K$28M+3.56%
Q3 2020724.6K$27M+4.03%
Q2 2020721.8K$24M+3.63%
Q1 2020713.9K$23M+4.11%
Q4 2019676.8K$27M+3.63%
Q3 2019683.3K$25M+3.49%
Q2 2019682.9K$30M+4.10%
Q1 2019668.9K$28M+4.20%
Q4 2018677.1K$30M+5.16%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Nexus Investment Management Ulc’s full portfolio or all institutional holders of PFE.